Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Golden Meditech Holdings Limited
Further Strengthen Competitive Advantages in Hospital Management Business
HONG KONG, July 18, 2014 /PRNewswire/ -- Golden Meditech Holdings Limited ("Golden Meditech", together with its subsidiaries collectively as the "Group", 801.HK; 910801.TW), a leading integrated healthcare enterprise in China announced today that GM Hospital Group Limited ("GMHG"), a non-wholly-owned subsidiary specialised in operating the hospital management business has increased its shareholdings in Beijing Qinghe Hospital ("Qinghe Hospital") to 82.73% for a cash consideration of approximately HK$154 million.
The Qinghe Hospital is located at Haidian District in Beijing which specialised not only in haematology but also provides a broad range of medical disciplines such as obstetrics and gynaecology, paediatrics, ophthalmology and dentistry. With a total floor area of approximately 75,000 m2, this hospital is designed to meet the highest healthcare standards in Mainland China, providing 600 beds, including 48 beds for the haematology wards.
Mr. Kam Yuen, Chairman and Chief Executive Officer of the Group, said, 'Golden Meditech has always been committed to developing hospital management business in Mainland China. The Qinghe Hospital has delivered progress that is in line with the management's expectation during the trial run. We are strongly convinced that the earnings momentum of hospital management business will start to gain traction and become our core growth driver in the future with rising contribution from Qinghe Hospital. We are delighted to take this timely opportunity to increase our interest in Qinghe Hospital, and strengthen our core competence and competitiveness through this transaction.' Mr. Kam continued, 'The demand for high quality healthcare services in Mainland China is and will continue to be driven by better living standards and government's dedication to promoting healthcare reforms in the long run. As we capitalize the market opportunity bought forth by the medical reforms, Golden Meditech will continue to focus on providing high-end medical products and services across Mainland China which is an expanding market full with unmatched demands.'
About Golden Meditech Holdings Limited
Golden Meditech Holdings Limited (www.goldenmeditech.com) is China's leading integrated-healthcare enterprise. Golden Meditech is a first-mover in China, having established dominant positions in medical devices, and cord blood storage and hospital management businesses of the healthcare services markets, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.
©2012 PR Newswire. All Rights Reserved.